Xencor
Price & Volume
Stats
See more52W Range | $10.37-$39.71 |
Market Cap | $2.6B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $200.4M |
Revenue Growth (YoY) | 454.9% |
Gross Profit (12 Mos) | -$85.2M |
Diluted EPS | -$1.56 |
News
See moreYahoo Finance • 2 days ago
Xencor Presents Initial Plamotamab Data in Rheumatoid Arthritis at ACR Convergence 2026 and Updates Progress in First-in-Human Study of XmAb657
Yahoo Finance • 6 days ago
Biotech Earnings: Who Won, Who Lost And Who Pulled Off A 'Historic' Launch?
Yahoo Finance • 17 days ago
Xencor reports promising kidney cancer drug results, plans late-stage trial
Yahoo Finance • last month
Raymond James Updates Healthcare Top Picks for October
About
CEO | Dr. Bassil I. Dahiyat Ph.D. |
CFO | Mr. Bart Jan Cornelissen |
Address | 465 North Halstead Street, Pasadena, CA, United States, 91107 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 260 |